1 – 10 of 34
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2023
- 
                        Mark
        Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair
    (2023) In Clinical cancer research : an official journal of the American Association for Cancer Research 29(22). p.4644-4659- Contribution to journal › Article
 
- 2022
- 
                        Mark
        Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
    
    - Contribution to journal › Article
 
- 
                        Mark
        Latest developments in metal complexes as anticancer agents
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
    
    - Contribution to journal › Scientific review
 
- 2021
- 
                        Mark
        In vitro nephrotoxicity studies of established and experimental platinum-based compounds
    
    - Contribution to journal › Article
 
- 2020
- 
                        Mark
        Cryogels with high cisplatin adsorption capacity : Towards removal of cytotoxic drugs from wastewater
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Tumor Regression and Cure Depends on Sustained Th1 Responses
    
    - Contribution to journal › Article
 
